English  |  正體中文  |  简体中文  |  Total items :2856713  
Visitors :  53615581    Online Users :  1352
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

Jump to a point in the index:
Or type in a year:
Show Most Recent First Ordering With Oldest First

Showing items 2224361-2224370 of 2349308  (234931 Page(s) Totally)
<< < 222432 222433 222434 222435 222436 222437 222438 222439 222440 222441 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-13T06:04:32Z Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors Liao B.-C.; Bai Y.-Y.; LEE JIH-HSIANG; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏 2021-07-13T06:04:33Z Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; LEE JIH-HSIANG; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏 2021-07-13T06:04:33Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2021-07-13T06:04:34Z Optimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapy Liao B.-C.; Lin C.-C.; LEE JIH-HSIANG; Yang J.C.-H.
臺大學術典藏 2021-07-13T06:04:34Z Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors Chang I.-S.; Jiang S.S.; Yang J.C.-H.; Su W.-C.; Chien L.-H.; Hsiao C.-F.; LEE JIH-HSIANG; Chen C.-Y.; Chen C.-H.; Chang G.-C.; Wang Z.; Lo F.-Y.; Chen K.-Y.; Wang W.-C.; Chen Y.-M.; Huang M.-S.; Tsai Y.-H.; Su Y.-C.; Hsieh W.-S.; Shih W.-C.; Shieh S.-H.; Yang T.-Y.; Lan Q.; Rothman N.; Chen C.-J.; Chanock S.J.; Yang P.-C.; Hsiung C.A.
臺大學術典藏 2021-07-13T06:04:35Z New data on clinical decisions in NSCLC patients with uncommon EGFR mutations Wu T.; Hsiue E.H.; LEE JIH-HSIANG; Lin C.; Yang J.C.
臺大學術典藏 2021-07-13T06:04:35Z A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer Soh S.X.; Siddiqui F.J.; Allen J.C.; Kim G.W.; Lee J.C.; Yatabe Y.; Soda M.; Mano H.; Soo R.A.; Chin T.-M.; Ebi H.; Yano S.; Matsuo K.; Niu X.; Lu S.; Isobe K.; LEE JIH-HSIANG; Yang J.C.; Zhao M.; Zhou C.; Lee J.-K.; Lee S.-H.; Lee J.Y.; Ahn M.-J.; Tan T.J.; Tan D.S.; Tan E.-H.; Ong S.T.; Lim W.-T.
臺大學術典藏 2021-07-13T06:04:35Z Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors Liao B.-C.; Lin C.-C.; LEE JIH-HSIANG; Yang J.C.-H.
臺大學術典藏 2021-07-13T06:04:36Z Safety of gefitinib in non-small cell lung cancer treatment Hsiue E.H.-C.; LEE JIH-HSIANG; Lin C.-C.; Yang J.C.-H.
臺大學術典藏 2021-07-13T06:04:36Z Profile of the therascreen? EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer Hsiue E.H.-C.; LEE JIH-HSIANG; Lin C.-C.; Yang J.C.-H.

Showing items 2224361-2224370 of 2349308  (234931 Page(s) Totally)
<< < 222432 222433 222434 222435 222436 222437 222438 222439 222440 222441 > >>
View [10|25|50] records per page